We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
NT to buy unless you buy just 2 shares! lols
We all know news is due , it’s a case of when not if. I’d hate to be out of Sar when it drops. FOMO after closing won’t be me.
MAJW knows that he is a little scoundrel.
Good luck all.
MAJW & the boys in the boiler room much be working their little cotton socks off!
Someone tell them it's not working.
Elcap
Can't hold it down for much longer - about to pop. Unless RF rescue the situation for them!
I cannot even buy at £1 on HL
MM's running out of shares. Do not short this stock.
30p resistance will be broken very soon
NT to buy?
Up we go, going to buy in again.
Another top up for 3500k .....
Having said that its looking like closing 30p or over
Of course its gone flat, and there is resistance we cant break through 30p.
Only posting this to illustrate our compounds are known by at least one big pharma. Whilst the patents only mention 1801/2 in the context of myriad other compounds, at least we're not flying totally under the radar. I came across the patents by searching the WIPO site for anything referencing SDC-1801 and then based on those results, limited it to results with "Gilead or MiroBio" AND "SDC-1801" -
https://patentscope.wipo.int/search/en/result.jsf?_vid=P12-LVCGCV-13961
MiroBio was an Oxford spinout acquired by Gilead for £332m - https://www.ox.ac.uk/news/2022-08-04-oxford-spinout-mirobio-acquired-gilead-sciences-405m
Onwards!
Er, Mr Nicely...'a bit flat' and earlier, 'resistance'...may I suggest looking more closely ? 😁
Getting the 30p ask, USA Players. That was your Caption
Still have just over an hour to go. Hopefully PEEL will be out of the way soon.
Up 30% this morning topping at 32p spread 5.5%
7am Rns
"Final Issue of RiverFort Subscription Shares "
The arrangement warned about by Hardman & co over from now on .
Would of been a great buy for the placement takers at 10p less then one month ago 28/3/24 .
Those buying into the 23% rise less then one week ago have made over 20% .
I am doing it all wrong lol
Ended of a bit flat really.
Exactly right Eazy and BA. Patent expirations in the pharma sector are on the rise for many of the major companies in our industry. They are often referred to as “Patent cliffs" and are a growing opportunity for much smaller bios, such as SAR. e.g. J&J‘s psoriasis treatment, Stelara, has annual sales of over $7 billion and targets psoriasis, psoriatic arthritis and Crohn’s disease and its patent appears be expiring in the next 2-3 years. Great news for Sareum's SDC1801. It's why many of us have been topping up with more SAR shares at these bargain basement prices....
Good luck, Brighty
Some good points there…
From July 2021 -
“The aim of this research project was to investigate the effects of SDC-1801, the Company's proprietary TYK2/JAK1 inhibitor, on cytokine signalling after SARS-CoV-2 infection. It was also designed to confirm whether an over-active inflammatory response (known as a 'cytokine storm') via the Interferon Type 1 pathway can be blocked in this disease by SDC-1801.
The project has completed on schedule, with the final results confirming the initial encouraging results as noted in the Company's Interim Results, published on 23 April 2021. The results of the project found that SDC-1801 reduced the levels of cytokines associated with Acute Respiratory Distress Syndrome (ARDS) in human lung cells infected with SARS-CoV-2 and demonstrated a profile that was superior to the anti-inflammatory steroid dexamethasone and similar to baricitinib, a JAK1/JAK2 inhibitor.”
Great summary Basil, strange how things work out, I made a few bob on these, over 1000% then RF came along and burst the bubble, RF gave me the chance to get in at crazy low prices I never thought I’d see again and ironically hold more SAR shares than ever, crazy how they almost killed this share but in long run could be great for LT share holders of bought at last weeks silly prices, the science never changed just the sentiment
Thanks for the clarification Basil - no problem
The fact that over 50% of global pharma pipelines are being externally sourced these days by licencing and takeover deals is excellent news for Sareum and its share holders. Our company also has its global patent ducks in a row and don't forget that Sareum has already produced data showing that SDC-1801 is superior to Dexamethasone in a trial. Plus, our science works in combo with Astra Zeneca's WEE1, Merck’s Keytruda, Eli Lilly's Gemcitabine. i.e. We are sitting on a gold mine. Not long to wait now for, hopefully, big news from Oz.
Carter19.
Eh?